To shed light on this enigma, we conducted an extensive analysis of ERK expression levels in breast cancer patients utilizing the GEPIA2 database (quartile cutoff), and the outcomes revealed that ERK2 but not ERK1 was prominently upregulated in four subtypes of breast cancer tissues (Fig. 3B and S4A). This evidence concerns the gene MAPK1 and breast cancer.